Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 356

1.

An official American Thoracic Society Workshop Report: presentations and discussion of the fifth Jack Pepys Workshop on Asthma in the Workplace. Comparisons between asthma in the workplace and non-work-related asthma.

Malo JL, Tarlo SM, Sastre J, Martin J, Jeebhay MF, Le Moual N, Heederik D, Platts-Mills T, Blanc PD, Vandenplas O, Moscato G, de Blay F, Cartier A; ATS ad hoc committee on Asthma in the Workplace.

Ann Am Thorac Soc. 2015 Jul;12(7):S99-S110. doi: 10.1513/AnnalsATS.201505-281ST.

2.

Manuscript cited in "Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement".

Malo JL.

Eur Respir J. 2014 Oct;44(4):1099-100. doi: 10.1183/09031936.00102614. No abstract available.

3.

EAACI Position Paper on assessment of cough in the workplace.

Moscato G, Pala G, Cullinan P, Folletti I, Gerth van Wijk R, Pignatti P, Quirce S, Sastre J, Toskala E, Vandenplas O, Walusiak-Skorupa J, Malo JL.

Allergy. 2014 Mar;69(3):292-304. doi: 10.1111/all.12352. Epub 2014 Jan 15. Review.

4.

Specific inhalation challenge with flour induced release of brain-derived neurotrophic factor in nasal fluid.

Castano R, Welman M, Trudeau C, Castellanos L, Maghni K, Malo JL.

Int Forum Allergy Rhinol. 2014 Jan;4(1):49-55. doi: 10.1002/alr.21223. Epub 2013 Sep 17.

PMID:
24106238
5.

Long-term socioprofessional and psychological status in workers investigated for occupational asthma in quebec.

Moullec G, Lavoie KL, Malo JL, Gautrin D, Lʼarchevêque J, Labrecque M.

J Occup Environ Med. 2013 Sep;55(9):1052-64. doi: 10.1097/JOM.0b013e31829904ab.

PMID:
23969504
6.

An official American Thoracic Society proceedings: work-related asthma and airway diseases. Presentations and discussion from the Fourth Jack Pepys Workshop on Asthma in the Workplace.

Tarlo SM, Malo JL; Fourth Jack Pepys Workshop on Asthma in the Workplace Participants.

Ann Am Thorac Soc. 2013 Aug;10(4):S17-24. doi: 10.1513/AnnalsATS.201305-119ST.

PMID:
23952871
7.

Prospective outcome assessment of occupational rhinitis after removal from exposure.

Castano R, Trudeau C, Castellanos L, Malo JL.

J Occup Environ Med. 2013 May;55(5):579-85. doi: 10.1097/JOM.0b013e318289ee17.

PMID:
23618893
8.

Prevalence of psychiatric disorders among patients investigated for occupational asthma: an overlooked differential diagnosis?

Lavoie KL, Joseph M, Favreau H, Lemiere C, Labrecque M, Cartier A, Malo JL, Gautrin D, Bacon SL.

Am J Respir Crit Care Med. 2013 May 1;187(9):926-32. doi: 10.1164/rccm.201211-2076OC.

PMID:
23491404
9.

What are the benefits of medical screening and surveillance?

Malo JL.

Eur Respir Rev. 2013 Mar 1;22(127):96. doi: 10.1183/09059180.00004212. No abstract available.

10.

Matrix metalloproteinase-9 increases in the sputum from allergic occupational asthma patients after specific inhalation challenge.

Castano R, Miedinger D, Maghni K, Ghezzo H, Trudeau C, Castellanos L, Wattiez M, Vandenplas O, Malo JL.

Int Arch Allergy Immunol. 2013;160(2):161-4. doi: 10.1159/000339737. Epub 2012 Sep 25.

PMID:
23018543
11.

CTNNA3 (α-catenin) gene variants are associated with diisocyanate asthma: a replication study in a Caucasian worker population.

Bernstein DI, Kashon M, Lummus ZL, Johnson VJ, Fluharty K, Gautrin D, Malo JL, Cartier A, Boulet LP, Sastre J, Quirce S, Germolec D, Tarlo SM, Cruz MJ, Munoz X, Luster MI, Yucesoy B.

Toxicol Sci. 2013 Jan;131(1):242-6. doi: 10.1093/toxsci/kfs272. Epub 2012 Sep 13.

12.

Distinct temporal patterns of immediate asthmatic reactions due to high- and low-molecular-weight agents.

Malo JL, Ghezzo H, L'archevêque J.

Clin Exp Allergy. 2012 Jul;42(7):1021-7. doi: 10.1111/j.1365-2222.2012.03970.x.

PMID:
22702501
13.

Genetic variants in antioxidant genes are associated with diisocyanate-induced asthma.

Yucesoy B, Johnson VJ, Lummus ZL, Kissling GE, Fluharty K, Gautrin D, Malo JL, Cartier A, Boulet LP, Sastre J, Quirce S, Germolec DR, Tarlo SM, Cruz MJ, Munoz X, Luster MI, Bernstein DI.

Toxicol Sci. 2012 Sep;129(1):166-73. doi: 10.1093/toxsci/kfs183. Epub 2012 May 17.

14.

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in nasal lavage after an inhalation challenge with flour.

Castano R, Miedinger D, Maghni K, Ghezzo H, Trudeau C, Castellanos L, Wattiez M, Vandenplas O, Malo JL.

Laryngoscope. 2012 Apr;122(4):730-5. doi: 10.1002/lary.23206. Epub 2012 Feb 28.

PMID:
22374842
15.

Feasibility of monitoring nasal and exhaled nitric oxide with a handheld analyzer during specific inhalation challenge.

Castano R, Miedinger D, Ghezzo H, Vandenplas O, Malo JL.

Ann Allergy Asthma Immunol. 2012 Jan;108(1):65-6. doi: 10.1016/j.anai.2011.10.008. Epub 2011 Nov 18. No abstract available.

PMID:
22192972
16.

Definitions and classification of work-related asthma.

Malo JL, Vandenplas O.

Immunol Allergy Clin North Am. 2011 Nov;31(4):645-62, v. doi: 10.1016/j.iac.2011.07.003. Review.

PMID:
21978849
17.

Identification of clinically significant psychological distress and psychiatric morbidity by examining quality of life in subjects with occupational asthma.

Miedinger D, Lavoie KL, L'Archeveque J, Ghezzo H, Malo JL.

Health Qual Life Outcomes. 2011 Sep 22;9:76. doi: 10.1186/1477-7525-9-76.

18.

Hexamethylene diisocyanate asthma is associated with genetic polymorphisms of CD14, IL-13, and IL-4 receptor α.

Bernstein DI, Kissling GE, Khurana Hershey G, Yucesoy B, Johnson VJ, Cartier A, Gautrin D, Sastre J, Boulet LP, Malo JL, Quirce S, Tarlo SM, Langmeyer S, Luster MI, Lummus ZL.

J Allergy Clin Immunol. 2011 Aug;128(2):418-20. doi: 10.1016/j.jaci.2011.03.007. Epub 2011 Apr 13. No abstract available.

19.

Asthma in reaction to two occupational agents in the same workplace.

Malo JL, L'Archevêque J.

Thorax. 2011 Nov;66(11):1008. doi: 10.1136/thx.2010.154831. Epub 2011 Apr 7. No abstract available.

PMID:
21474500
20.

Direct costs of occupational asthma due to sensitization in Quebec (1988 to 2002): revisited.

Malo JL, Zunzunegui MV, L'Archevêque J, Cardinal S, Ghezzo H.

Can Respir J. 2011 Jan-Feb;18(1):e1-5.

Supplemental Content

Support Center